Syneron Medical (ELOS) Stock Price, News & Analysis

Company Overview

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Key Stats

• Today's Range: $11.00 to $11.00
• 50-Day Range: N/A
• 52-Week Range: $6.18 to $11.43
• Volume: N/A
• Average Volume: 562,777 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ELOS Stock Analysis - Frequently Asked Questions

How were Syneron Medical's earnings last quarter?

Syneron Medical Ltd (NASDAQ:ELOS) announced its earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.06 by $0.03. The business's revenue was up 2.0% on a year-over-year basis.

What other stocks do shareholders of Syneron Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Syneron Medical investors own include Micron Technology (MU), Cisco Systems (CSCO), Vale (VALE), Intel (INTC), Lannett (LCI), Advanced Micro Devices (AMD) and General Motors (GM).

Company Calendar

• Last Earnings: 8/04/2016
• Today: 7/26/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ELOS
• CIK: 1291361
• Web: syneron-candela.com
• Phone: +972-7-32442200
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A